A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma

C. R. Crawley, J. M. Foran, R. K. Gupta, A. Z.S. Rohatiner, K. Summers, J. Matthews, I. N.M. Micallef, J. A. Radford, S. A. Johnson, P. W. Johnson, J. W. Sweetenham, T. A. Lister

Research output: Contribution to journal › Article › peer-review